Literature DB >> 19481242

Adjuvant radiotherapy in patients with vulvar cancer and one intra capsular lymph node metastasis is not beneficial.

G Fons1, S M A Groenen, M H M Oonk, A C Ansink, A G J van der Zee, M P M Burger, L J A Stalpers, J van der Velden.   

Abstract

AIM OF THE STUDY: The aim of the study was to analyze the benefit from adjuvant radiotherapy in patients with vulvar cancer and a single positive node without extra capsular spread.
MATERIALS AND METHODS: The study population comprised data of 75 patients with vulvar cancer and one lymph node metastasis. The patients were treated in three different university centers in Amsterdam, Groningen and Rotterdam between 1984 and 2005.
RESULTS: Out of 75 patients, 31 (41%) were treated with adjuvant radiotherapy. Both disease-free survival (DFS) and disease-specific survival (DSS) were comparable between the groups who did and who did not receive adjuvant radiotherapy (HR 0.98, 95% CI 0.45-2.14, p=0.97 and HR=1.02, 95% CI 0.42-2.47, p=0.96).
CONCLUSION: We could not demonstrate any beneficial effect of adjuvant radiotherapy in the group of patients with one intra capsular metastasis.

Entities:  

Mesh:

Year:  2009        PMID: 19481242     DOI: 10.1016/j.ygyno.2009.05.017

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  Management of patients with vulvar cancer: a perspective review according to tumour stage.

Authors:  Linn Woelber; Fabian Trillsch; Lilli Kock; Donata Grimm; Cordula Petersen; Matthias Choschzick; Fritz Jaenicke; Sven Mahner
Journal:  Ther Adv Med Oncol       Date:  2013-05       Impact factor: 8.168

2.  Adjuvant Radiation in Early Stage Vulvar Cancer: A Review of Indications and Optimal Dose.

Authors:  Karishma Khullar; Tomas Patrich; Salma K Jabbour; Lara Hathout
Journal:  Appl Radiat Oncol       Date:  2022-03

3.  Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study.

Authors:  Sven Mahner; Julia Jueckstock; Felix Hilpert; Petra Neuser; Philipp Harter; Nikolaus de Gregorio; Annette Hasenburg; Jalid Sehouli; Annika Habermann; Peter Hillemanns; Sophie Fuerst; Hans-Georg Strauss; Klaus Baumann; Falk Thiel; Alexander Mustea; Werner Meier; Andreas du Bois; Lis-Femke Griebel; Linn Woelber
Journal:  J Natl Cancer Inst       Date:  2015-01-24       Impact factor: 13.506

4.  Cancer of the vulva: 2021 update.

Authors:  Alexander B Olawaiye; Mauricio A Cuello; Linda J Rogers
Journal:  Int J Gynaecol Obstet       Date:  2021-10       Impact factor: 4.447

5.  Prognostic factors in patients with vulvar cancer treated with primary surgery: a single-center experience.

Authors:  Sayaka Imoto; Morihiko Inamine; Wataru Kudaka; Yutaka Nagai; Akihiko Wakayama; Tomoko Nakamoto; Takuma Ooyama; Yoichi Aoki
Journal:  Springerplus       Date:  2016-02-18

Review 6.  Vulvar carcinoma: dilemma, debates, and decisions.

Authors:  Swarupa Mitra; Manoj Kumar Sharma; Inderjeet Kaur; Ruparna Khurana; Kanika Batra Modi; Raman Narang; Avik Mandal; Soumya Dutta
Journal:  Cancer Manag Res       Date:  2018-01-09       Impact factor: 3.989

7.  Long Term Results of Radiotherapy in Vulvar Cancer Patients in Slovenia between 1997-2004.

Authors:  Helena Barbara Zobec Logar
Journal:  Radiol Oncol       Date:  2017-06-16       Impact factor: 2.991

8.  Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer.

Authors:  Toshiaki Saito; Tsutomu Tabata; Hitoshi Ikushima; Hiroyuki Yanai; Hironori Tashiro; Hitoshi Niikura; Takeo Minaguchi; Toshinari Muramatsu; Tsukasa Baba; Wataru Yamagami; Kazuya Ariyoshi; Kimio Ushijima; Mikio Mikami; Satoru Nagase; Masanori Kaneuchi; Nobuo Yaegashi; Yasuhiro Udagawa; Hidetaka Katabuchi
Journal:  Int J Clin Oncol       Date:  2017-11-20       Impact factor: 3.402

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.